CD105 expression has been associated with poor prognosis in several cancers, including ovarian cancer [23,24,25], and high CD105 expression is associated with increased levels of metastasis in oral, lung, liver, and pancreatic cancer [26,27,28,29]. This evidence concerns the gene ENG and ovarian carcinoma.